An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model

BACKGROUND: Transplantation of gene transfected endothelial progenitor cells (EPCs) has provided novel methods for tumor neovascularization therapy but not for ocular disease therapy. This study aimed to investigate the efficacy of endostatin transfected EPCs in retinal neovascularization therapy. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Jing, Ma, Jian, Chen, Zhi-Qing, Sun, Jun-Hui, Yao, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392664/
https://www.ncbi.nlm.nih.gov/pubmed/32727534
http://dx.doi.org/10.1186/s12860-020-00301-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392664/
https://www.ncbi.nlm.nih.gov/pubmed/32727534
http://dx.doi.org/10.1186/s12860-020-00301-1

Ejemplares similares